Mark van der Linden

Overview

Best Publications

• Rapid Pneumococcal Evolution in Response to Clinical Interventions

  Nicholas J. Croucher;Simon R. Harris;Christophe Fraser;Michael A. Quail

  1024
  Citations

• Changes in the incidence of invasive disease due to Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis during the COVID-19 pandemic in 26 countries and territories in the Invasive Respiratory Infection Surveillance Initiative: a prospective analysis of surveillance data.

  Angela B. Brueggemann;Melissa J. Jansen van Rensburg;David Shaw;Noel D. McCarthy

  501
  Citations

• Clinical and Microbiological Characteristics of Severe Streptococcus pyogenes Disease in Europe

  Bogdan Luca-Harari;Jessica Darenberg;Shona Neal;Tuula Siljander

  359
  Citations

• The NLRP3 inflammasome is differentially activated by pneumolysin variants and contributes to host defense in pneumococcal pneumonia.

  Martin Witzenrath;Florence Pache;Daniel Lorenz;Uwe Koppe

  302
  Citations

• Antimicrobial Susceptibility of Streptococcus pneumoniae in Eight European Countries from 2001 to 2003

  Ralf René Reinert;Susanne Reinert;Mark van der Linden;Murat Y. Cil

  249
  Citations

• Acquisition of five high-Mr penicillin-binding protein variants during transfer of high-level beta-lactam resistance from Streptococcus mitis to Streptococcus pneumoniae.

  Regine Hakenbeck;Andrea König;Izabella Kern;Mark van der Linden

  245
  Citations

• Prevention of pneumococcal diseases in the post-seven valent vaccine era: A European perspective

  Catherine Weil-Olivier;Mark van der Linden;Iris de Schutter;Ron Dagan

  181
  Citations

• Diallylthiosulfinate (Allicin), a Volatile Antimicrobial from Garlic (Allium sativum), Kills Human Lung Pathogenic Bacteria, Including MDR Strains, as a Vapor

  Jana Reiter;Natalja Levina;Mark van der Linden;Martin Gruhlke

  173
  Citations

• Trends in invasive bacterial diseases during the first 2 years of the COVID-19 pandemic: analyses of prospective surveillance data from 30 countries and territories in the IRIS Consortium

  Unknown

  163
  Citations

• Clinical and Epidemiological Aspects of Invasive Streptococcus pyogenes Infections in Denmark during 2003 and 2004

  Bogdan Luca-Harari;Kim Ekelund;Kim Ekelund;Mark van der Linden;Margit Staum-Kaltoft

  158
  Citations

• Effects of Infant Pneumococcal Conjugate Vaccination on Serotype Distribution in Invasive Pneumococcal Disease among Children and Adults in Germany.

  Mark van der Linden;Gerhard Falkenhorst;Stephanie Perniciaro;Matthias Imöhl

  157
  Citations

• Evidence for Soft Selective Sweeps in the Evolution of Pneumococcal Multidrug Resistance and Vaccine Escape

  Nicholas J. Croucher;Nicholas J. Croucher;Claire Chewapreecha;William P. Hanage;Simon R. Harris

  144
  Citations

• Reduction in the incidence of invasive pneumococcal disease after general vaccination with 7-valent pneumococcal conjugate vaccine in Germany.

  Simon Rückinger;Mark van der Linden;Ralf René Reinert;Rüdiger von Kries

  140
  Citations

• Pneumococcal polysaccharide vaccination for adults: new perspectives for Europe.

  David S Fedson;Laurence Nicolas-Spony;Peter Klemets;Mark van der Linden

  140
  Citations

• Penicillin-Binding Proteins in β-Lactam–Resistant Streptococcus pneumoniae

  Regine Hakenbeck;Kristina Kaminski;Andrea König;Mark Van Der Linden

  131
  Citations

• Association of serotype of Streptococcus pneumoniae with risk of severe and fatal outcome.

  Simon Rückinger;Rüdiger von Kries;Annette Siedler;Mark van der Linden

  130
  Citations

• Increase of serotypes 15A and 23B in IPD in Germany in the PCV13 vaccination era

  Mark van der Linden;Stephanie Perniciaro;Matthias Imöhl

  121
  Citations

• Detection of Large Numbers of Pneumococcal Virulence Genes in Streptococci of the Mitis Group

  Calum Johnston;Jason Hinds;Andrew Smith;Mark van der Linden

  106
  Citations

• The Burden of Pneumococcal Pneumonia – Experience of the German Competence Network CAPNETZ

  M. W. Pletz;H. von Baum;M. van der Linden;G. Rohde

  101
  Citations

• Molecular Epidemiology of Macrolide-Resistant Streptococcus pneumoniae Isolates in Europe

  Ralf René Reinert;Adrian Ringelstein;Mark van der Linden;Murat Yücel Cil

  98
  Citations

• Effectiveness of Pneumococcal Conjugate Vaccines (PCV7 and PCV13) against Invasive Pneumococcal Disease among Children under Two Years of Age in Germany.

  Mark van der Linden;Gerhard Falkenhorst;Stephanie Perniciaro;Christina Fitzner

  89
  Citations

• Discovery of Streptococcus pneumoniae serotype 6 variants with glycosyltransferases synthesizing two differing repeating units

  Melissa B. Oliver;Mark P. G. van der Linden;Sharon A. Küntzel;Jamil S. Saad

  88
  Citations

• Variable recombination dynamics during the emergence, transmission and ‘disarming’ of a multidrug-resistant pneumococcal clone

  Nicholas J. Croucher;Nicholas J. Croucher;Nicholas J. Croucher;William P. Hanage;Simon R. Harris;Lesley McGee

  83
  Citations